Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution
Menu

Contact Us
If you have any questions or feedback please contact us.

Susan L. Calcaterra

TitleAssociate Professor
InstitutionUniversity of Colorado Denver - Anschutz Medical Campus
DepartmentSOM-MED

    Collapse Research 
    Collapse research activities and funding
    K08DA049905     (CALCATERRA, SUSAN L)Apr 1, 2020 - Mar 31, 2025
    NIH
    Understanding Factors that Limit Access to Opioid Use Disorder Treatment in the Hospital to Inform Innovative Approaches to Expand Hospital-Based Treatment
    Role: Principal Investigator

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    List All   |   Timeline
    1. Calcaterra SL, Peterkin AF. Antiracist Strategies to Combat Racial Disparities in the Delivery of Hospital-Based Addiction Care. J Gen Intern Med. 2024 Feb; 39(2):165-167. PMID: 37848761.
      View in: PubMed
    2. Callister C, Porter S, Vatterott P, Keniston A, McBeth L, Mann S, Calcaterra SL, Limes J. The Impact of Completing X-Waiver Training and Clinical Addiction Exposure on Internal Medicine Residents Treating Patients With Opioid Use Disorder. Subst Use Addctn J. 2024 Jan 07; 29767342231221004. PMID: 38258815.
      View in: PubMed
    3. Stern SJ, D'Orazio JL, Work BD, Calcaterra SL, Thakrar AP. Point/counterpoint: Should full agonist opioid medications be offered to hospitalized patients for management of opioid withdrawal? J Hosp Med. 2024 Apr; 19(4):339-343. PMID: 38030816.
      View in: PubMed
    4. Calcaterra SL, Saunders S, Grimm E, Maki-Gianani E, Keniston A, Wold A, Bonaguidi A. In-Hospital Methadone Enrollment: a Novel Program to Facilitate Linkage from the Hospital to the Opioid Treatment Program for Vulnerable Patients with Opioid Use Disorder. J Gen Intern Med. 2024 Feb; 39(3):385-392. PMID: 37715094.
      View in: PubMed
    5. Calcaterra SL, Lockhart S, Natvig C, Mikulich S. Barriers to initiate buprenorphine and methadone for opioid use disorder treatment with postdischarge treatment linkage. J Hosp Med. 2023 10; 18(10):896-907. PMID: 37608527.
      View in: PubMed
    6. Martin M, Englander H, Calcaterra SL. Things We Do for No Reason?: Avoiding methadone for opioid withdrawal. J Hosp Med. 2023 11; 18(11):1034-1037. PMID: 37244869.
      View in: PubMed
    7. Calcaterra SL, Martin M, Englander H. Identifying Barriers to OUD Treatment Linkage From the Emergency Department to the Community. JAMA Netw Open. 2023 05 01; 6(5):e2312683. PMID: 37163270.
      View in: PubMed
    8. Terasaki D, Kulick B, Calcaterra S, Ray L. Phenobarbital for alcohol withdrawal in the context of the opioid epidemic: a neglected caveat. Addiction. 2023 07; 118(7):1198-1200. PMID: 36967706.
      View in: PubMed
    9. Calcaterra SL, Buresh M, Weimer MB. Better care?at the?bedside for hospitalized patients with opioid use disorder. J Hosp Med. 2023 12; 18(12):1134-1138. PMID: 37016586.
      View in: PubMed
    10. Jawa R, Tin Y, Nall S, Calcaterra SL, Savinkina A, Marks LR, Kimmel SD, Linas BP, Barocas JA. Estimated Clinical Outcomes and Cost-effectiveness Associated With Provision of Addiction Treatment in US Primary Care Clinics. JAMA Netw Open. 2023 04 03; 6(4):e237888. PMID: 37043198.
      View in: PubMed
    11. Calcaterra SL, Grimm E, Keniston A. External validation of a model to predict future chronic opioid use among hospitalized patients. J Hosp Med. 2023 02; 18(2):154-162. PMID: 36524583.
      View in: PubMed
    12. Bredenberg E, Tietbohl C, Dafoe A, Thurman L, Calcaterra S. Identifying factors that contribute to burnout and resilience among hospital-based addiction medicine providers: A qualitative study. J Subst Abuse Treat. 2023 01; 144:108924. PMID: 36327617.
      View in: PubMed
    13. Calcaterra SL, Bottner R, Martin M, Englander H, Weinstein ZM, Weimer MB, Lambert E, Ronan MV, Huerta S, Zaman T, Ullal M, Peterkin AF, Torres-Lockhart K, Buresh M, O'Brien MT, Snyder H, Herzig SJ. Management of opioid use disorder, opioid withdrawal, and opioid overdose prevention in hospitalized adults: A systematic review of existing guidelines. J Hosp Med. 2022 09; 17(9):679-692. PMID: 35880821.
      View in: PubMed
    14. Calcaterra SL, Martin M, Bottner R, Englander H, Weinstein Z, Weimer MB, Lambert E, Herzig SJ. Management of opioid use disorder and associated conditions among hospitalized adults: A Consensus Statement from the Society of Hospital Medicine. J Hosp Med. 2022 09; 17(9):744-756. PMID: 35880813.
      View in: PubMed
    15. Calcaterra SL, Butler M, Olson K, Blum J. The Impact of a PDMP-EHR Data Integration Combined With Clinical Decision Support on Opioid and Benzodiazepine Prescribing Across Clinicians in a Metropolitan Area. J Addict Med. 2022 May-Jun 01; 16(3):324-332. PMID: 34392255.
      View in: PubMed
    16. Bredenberg E, Hanna RM, Kotwas M, Singh S, Calcaterra SL. Inequities in treatment of substance use disorders among people with limited English proficiency. J Hosp Med. 2022 07; 17(7):569-571. PMID: 35451241.
      View in: PubMed
    17. Calcaterra SL, Lockhart S, Callister C, Hoover K, Binswanger IA. Opioid Use Disorder Treatment Initiation and Continuation: a Qualitative Study of Patients Who Received Addiction Consultation and Hospital-Based Providers. J Gen Intern Med. 2022 08; 37(11):2786-2794. PMID: 34981359.
      View in: PubMed
    18. Awadallah NS, Rollins V, Oung AB, Dickinson M, de la Cerda D, Calcaterra S, Orr J, Grushan M. An Interprofessional Approach to Chronic Pain Management and Education. Fam Med. 2022 01; 54(1):47-53. PMID: 35006600.
      View in: PubMed
    19. Hoover K, Lockhart S, Callister C, Holtrop JS, Calcaterra SL. Experiences of stigma in hospitals with addiction consultation services: A qualitative analysis of patients' and hospital-based providers' perspectives. J Subst Abuse Treat. 2022 07; 138:108708. PMID: 34991950.
      View in: PubMed
    20. Callister C, Lockhart S, Holtrop JS, Hoover K, Calcaterra SL. Experiences with an addiction consultation service on care provided to hospitalized patients with opioid use disorder: a qualitative study of hospitalists, nurses, pharmacists, and social workers. Subst Abus. 2022; 43(1):615-622. PMID: 34666634.
      View in: PubMed
    21. Calcaterra SL, McBeth L, Keniston AM, Burden M. The Development and Implementation of a Hospitalist-Directed Addiction Medicine Consultation Service to Address a Treatment Gap. J Gen Intern Med. 2022 04; 37(5):1065-1072. PMID: 34013473.
      View in: PubMed
    22. Ritvo AD, Calcaterra SL, Ritvo JI. Using Extended Release Buprenorphine Injection to Discontinue Sublingual Buprenorphine: A Case Series. J Addict Med. 2021 May-Jun 01; 15(3):252-254. PMID: 32925232.
      View in: PubMed
    23. Calcaterra SL, Lou Y, Everhart RM, Fish LE, Hanratty R. Association Between In-Clinic Opioid Administration and Discharge Opioid Prescription in Urgent Care: a Retrospective Cohort Study. J Gen Intern Med. 2021 01; 36(1):43-50. PMID: 32728954.
      View in: PubMed
    24. Calcaterra SL, Burnett-Hartman AN, Powers JD, Corley DA, McMullen CM, Pawloski PA, Feigelson HS. A population-based survey to assess the association between cannabis and quality of life among colorectal cancer survivors. BMC Cancer. 2020 May 03; 20(1):373. PMID: 32362277.
      View in: PubMed
    25. Calcaterra SL, Binswanger IA, Edelman EJ, McNair BK, Wakeman SE, O'Connor PG. The impact of access to addiction specialist on attitudes, beliefs and hospital-based opioid use disorder related care: A survey of hospitalist physicians. Subst Abus. 2022; 43(1):143-151. PMID: 32267807.
      View in: PubMed
    26. Calcaterra SL, Klie KA. Methadone, Buprenorphine, or Detoxification for Management of Perinatal Opioid Use Disorder: A Cost-Effectiveness Analysis. Obstet Gynecol. 2020 04; 135(4):975. PMID: 32217961.
      View in: PubMed
    27. Joudrey PJ, Chadi N, Roy P, Morford KL, Bach P, Kimmel S, Wang EA, Calcaterra SL. Pharmacy-based methadone dispensing and drive time to methadone treatment in five states within the United States: A cross-sectional study. Drug Alcohol Depend. 2020 Mar 27; 211:107968. PMID: 32268248.
      View in: PubMed
    28. Calcaterra SL, Cunningham CO, Hopfer CJ. The Void in Clinician Counseling of Cannabis Use. J Gen Intern Med. 2020 06; 35(6):1875-1878. PMID: 31898125.
      View in: PubMed
    29. Englander H, Priest KC, Snyder H, Martin M, Calcaterra S, Gregg J. A Call to Action: Hospitalists' Role in Addressing Substance Use Disorder. J Hosp Med. 2019 Oct 23; 14:E1-E4. PMID: 31634100.
      View in: PubMed
    30. Terasaki D, Smith C, Calcaterra SL. Transitioning Hospitalized Patients with Opioid Use Disorder from Methadone to Buprenorphine without a Period of Opioid Abstinence Using a Microdosing Protocol. Pharmacotherapy. 2019 10; 39(10):1023-1029. PMID: 31348544.
      View in: PubMed
    31. Calcaterra SL, Hopfer CJ, Keniston A, Hull ML. Changes in Healthcare Encounter Rates Possibly Related to Cannabis or Alcohol following Legalization of Recreational Marijuana in a Safety-Net Hospital: An Interrupted Time Series Analysis. J Addict Med. 2019 May/Jun; 13(3):201-208. PMID: 30475257.
      View in: PubMed
    32. Binswanger IA, Narwaney KJ, Gardner EM, Gabella BA, Calcaterra SL, Glanz JM. Development and evaluation of a standardized research definition for opioid overdose outcomes. Subst Abus. 2019; 40(1):71-79. PMID: 30875477.
      View in: PubMed
    33. Calcaterra SL, Bach P, Chadi A, Chadi N, Kimmel SD, Morford KL, Roy P, Samet JH. Methadone Matters: What the United States Can Learn from the Global Effort to Treat Opioid Addiction. J Gen Intern Med. 2019 06; 34(6):1039-1042. PMID: 30729416.
      View in: PubMed
    34. Kennedy LC, Binswanger IA, Mueller SR, Levy C, Matlock DD, Calcaterra SL, Koester S, Frank JW. "Those Conversations in My Experience Don't Go Well": A Qualitative Study of Primary Care Provider Experiences Tapering Long-term Opioid Medications. Pain Med. 2018 11 01; 19(11):2201-2211. PMID: 29126138.
      View in: PubMed
    35. Herzig SJ, Mosher HJ, Calcaterra SL, Nuckols TK. Reply to "In Reference to 'Improving the Safety of Opioid Use for Acute Noncancer Pain in Hospitalized Adults: A Consensus Statement from the Society of Hospital Medicine'". J Hosp Med. 2018 09; 13(10):728. PMID: 30261091.
      View in: PubMed
    36. Calcaterra SL, Severtson SG, Bau GE, Margolin ZR, Bucher-Bartelson B, Green JL, Dart RC. Trends in intentional abuse or misuse of benzodiazepines and opioid analgesics and the associated mortality reported to poison centers across the United States from 2000 to 2014. Clin Toxicol (Phila). 2018 11; 56(11):1107-1114. PMID: 29609498.
      View in: PubMed
    37. Herzig SJ, Mosher HJ, Calcaterra SL, Jena AB, Nuckols TK. Improving the Safety of Opioid Use for Acute Noncancer Pain in Hospitalized Adults: A Consensus Statement From the Society of Hospital Medicine. J Hosp Med. 2018 04; 13(4):263-271. PMID: 29624189.
      View in: PubMed
    38. Herzig SJ, Calcaterra SL, Mosher HJ, Ronan MV, Groningen NV, Shek L, Loffredo A, Keller M, Jena AB, Nuckols TK. Safe Opioid Prescribing for Acute Noncancer Pain in Hospitalized Adults: A Systematic Review of Existing Guidelines. J Hosp Med. 2018 04; 13(4):256-262. PMID: 29624188.
      View in: PubMed
    39. Calcaterra SL, Scarbro S, Hull ML, Forber AD, Binswanger IA, Colborn KL. Prediction of Future Chronic Opioid Use Among Hospitalized Patients. J Gen Intern Med. 2018 06; 33(6):898-905. PMID: 29404943.
      View in: PubMed
    40. Glanz JM, Narwaney KJ, Mueller SR, Gardner EM, Calcaterra SL, Xu S, Breslin K, Binswanger IA. Prediction Model for Two-Year Risk of Opioid Overdose Among Patients Prescribed Chronic Opioid Therapy. J Gen Intern Med. 2018 10; 33(10):1646-1653. PMID: 29380216.
      View in: PubMed
    41. Yogo N, Shihadeh K, Young H, Calcaterra SL, Knepper BC, Burman WJ, Mehler PS, Jenkins TC. Intervention to Reduce Broad-Spectrum Antibiotics and Treatment Durations Prescribed at the Time of Hospital Discharge: A Novel Stewardship Approach. Infect Control Hosp Epidemiol. 2017 05; 38(5):534-541. PMID: 28260538.
      View in: PubMed
    42. Calcaterra SL, Drabkin AD, Doyle R, Leslie SE, Binswanger IA, Frank JW, Reich JA, Koester S. A Qualitative Study of Hospitalists' Perceptions of Patient Satisfaction Metrics on Pain Management. Hosp Top. 2017 Jan-Mar; 95(1):18-26. PMID: 28362247.
      View in: PubMed
    43. Frank JW, Levy C, Calcaterra SL, Hoppe JA, Binswanger IA. Naloxone Administration in US Emergency Departments, 2000-2011. J Med Toxicol. 2016 06; 12(2):148-56. PMID: 26621354.
      View in: PubMed
    44. Frank JW, Levy C, Matlock DD, Calcaterra SL, Mueller SR, Koester S, Binswanger IA. Patients' Perspectives on Tapering of Chronic Opioid Therapy: A Qualitative Study. Pain Med. 2016 10; 17(10):1838-1847. PMID: 27207301.
      View in: PubMed
    45. Calcaterra SL, Drabkin AD, Leslie SE, Doyle R, Koester S, Frank JW, Reich JA, Binswanger IA. The hospitalist perspective on opioid prescribing: A qualitative analysis. J Hosp Med. 2016 08; 11(8):536-42. PMID: 27157317.
      View in: PubMed
    46. Calcaterra SL, Yamashita TE, Min SJ, Keniston A, Frank JW, Binswanger IA. Opioid Prescribing at Hospital Discharge Contributes to Chronic Opioid Use. J Gen Intern Med. 2016 May; 31(5):478-85. PMID: 26553336.
      View in: PubMed
    47. Frank JW, Binswanger IA, Calcaterra SL, Brenner LA, Levy C. Non-medical use of prescription pain medications and increased emergency department utilization: Results of a national survey. Drug Alcohol Depend. 2015 Dec 01; 157:150-7. PMID: 26564754.
      View in: PubMed
    48. Mueller SR, Walley AY, Calcaterra SL, Glanz JM, Binswanger IA. A Review of Opioid Overdose Prevention and Naloxone Prescribing: Implications for Translating Community Programming Into Clinical Practice. Subst Abus. 2015; 36(2):240-53. PMID: 25774771.
      View in: PubMed
    49. Calcaterra SL, Keniston A, Blum J, Crume T, Binswanger IA. The Association Between Stimulant, Opioid, and Multiple Drug Use on Behavioral Health Care Utilization in a Safety-Net Health System. Subst Abus. 2015; 36(4):407-12. PMID: 25738222.
      View in: PubMed
    50. Calcaterra SL, Beaty B, Mueller SR, Min SJ, Binswanger IA. The association between social stressors and drug use/hazardous drinking among former prison inmates. J Subst Abuse Treat. 2014 Jul; 47(1):41-9. PMID: 24642070.
      View in: PubMed
    51. Calcaterra S, Glanz J, Binswanger IA. National trends in pharmaceutical opioid related overdose deaths compared to other substance related overdose deaths: 1999-2009. Drug Alcohol Depend. 2013 Aug 01; 131(3):263-70. PMID: 23294765.
      View in: PubMed
    52. Calcaterra S, Binswanger IA. National trends in psychostimulant-related deaths: 1999-2009. Subst Abus. 2013; 34(2):129-36. PMID: 23577906.
      View in: PubMed
    53. Calcaterra S, Blatchford P, Friedmann PD, Binswanger IA. Psychostimulant-related deaths among former inmates. J Addict Med. 2012 Jun; 6(2):97-105. PMID: 22134174.
      View in: PubMed
    54. Bove SE, Calcaterra SL, Brooker RM, Huber CM, Guzman RE, Juneau PL, Schrier DJ, Kilgore KS. Weight bearing as a measure of disease progression and efficacy of anti-inflammatory compounds in a model of monosodium iodoacetate-induced osteoarthritis. Osteoarthritis Cartilage. 2003 Nov; 11(11):821-30. PMID: 14609535.
      View in: PubMed
    Calcaterra's Networks
    Click the "See All" links for more information and interactive visualizations!
    Concepts Expand Description
    See all (169) concept(s)
    _
    Co-Authors Expand Description
    See all (37) people
    _
    Similar People Expand Description
    See all (60) people
    _
    Same Department Expand Description
    Search Department

    Copyright © 2024 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)